Diplomat: The EU envoy failed to reach an agreement on the 15th round of sanctions against Russia.Senior energy safety official: Poland will start looking for partners for the construction of the second nuclear power plant in early 2025.In November, Sichuan CPI rose by 0.1% year-on-year, and the price increase of pork and fresh vegetables dropped from the previous month. On December 10, the data released by the Sichuan Survey Corps of the National Bureau of Statistics showed that the consumer price index (CPI) in Sichuan rose by 0.1% year-on-year, and the growth rate dropped by 0.1 percentage point from the previous month. It decreased by 0.7% from the previous month. From January to November, the consumer price of Sichuan residents decreased by 0.1% compared with the same period of last year. In terms of food, the price of food, tobacco and alcohol rose by 1.8% year-on-year in November, and the growth rate dropped by 1.1 percentage points from the previous month. Among them, the prices of pork and fresh vegetables increased by 15.2% and 14.0% year-on-year, respectively, and the growth rate dropped from last month; The price of fresh fruit changed from a year-on-year increase of 3.4% last month to an increase of 2.0%; The prices of eggs and aquatic products decreased by 1.6% and 0.6% respectively. From the ring comparison, the price of food, tobacco and alcohol decreased by 1.9% from 0.3% last month, mainly because the average temperature in November was higher than that in previous years, which was beneficial to the production, storage and transportation of agricultural products, and most fresh food prices were affected by the super-seasonal decline.
The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)Modern Investment: Xu Qing, the independent director of the company, was subject to disciplinary review and supervision investigation. According to the announcement of Modern Investment, Xu Qing, the independent director of the company, was suspected of serious violation of discipline and law, and is currently subject to disciplinary review by the Disciplinary Committee of Hunan Branch of Industrial and Commercial Bank of China and supervision investigation by Zhuzhou Municipal Supervision Committee. Xu Qing did not hold any other positions in the company except as an independent director, chairman of the Nomination Committee of the Board of Directors, member of the Strategy Committee of the Board of Directors and member of the Audit Committee of the Board of Directors, and did not participate in the daily operation and management of the company. The company will pay attention to the subsequent progress and fulfill its information disclosure obligations in a timely manner in strict accordance with relevant regulations.Iran's Supreme Leader Ayatollah Ali Khamenei: Since September, Iran has issued a warning to the Assad government about the threat, but it has ignored the "enemy".
The price of gold is expected to break through the market. The key data of the United States are expected tonight, and the price of gold is basically flat on Wednesday. The market expects the key inflation data of the United States, which may affect the general expectation of interest rate cuts and provide more clues for the outlook in 2025. Rhona O‘Connell, an analyst at StoneX, said that the market is concerned about the upcoming inflation data and will pay attention to President Powell's post-meeting comments next week for further policy insights. O' Connell added that the price of gold was once stagnant but showing signs of recovery. The recent rebound was driven by geopolitical risks, and the price of gold reached the upper limit of the range, but did not break through the high point. Kyle Rodda, a financial market analyst in Capital.com, said: "The expected data almost gives the Fed a green light to cut interest rates next week, which may be a gold price catalyst." Goldman Sachs said that the main downside risk of predicting that gold will be $3,000 per ounce by the end of 2025 is that the Fed will cut interest rates, not that the dollar will strengthen. Goldman Sachs predicts: "If the Fed cuts interest rates again, the price of gold will rise to $2,890 per ounce."Ningbo Founder: The company intends to use its own or self-raised funds to purchase 40% equity of Junpeng Communication from related party Pengxin Chuangzhan in cash. Ningbo Founder announced that the company intends to use its own or self-raised funds to purchase 40% equity of Junpeng Communication from related party Pengxin Chuangzhan in cash.Wanfang Development: A supplementary agreement on equity transfer of RMB 12.3 million was signed, and Wanfang Development announced that the company held the 66th meeting of the 9th Board of Directors on December 11th, 2024, at which the Proposal on the Progress of Selling a wholly-owned subsidiary and Signing a Supplementary Agreement was reviewed and approved. The Company signed Supplementary Agreement III to the Equity Transfer Agreement with Beijing Tianyuan and Beijing Baiyu, and Beijing Baiyu will pay the remaining equity transfer amount of RMB 12.3 million to the Company before December 31, 2025. As of the disclosure date of the announcement, Beijing Baiyu has paid 77.7 million yuan of equity transfer to the company, and the remaining 12.3 million yuan of equity transfer has not been paid. The company has transferred its 86.3333% equity of Beijing Tianyuan to Beijing Baiyu, so far, the company holds 13.6667% equity of Beijing Tianyuan.
Strategy guide
Strategy guide 12-13
Strategy guide